Clinical Trials Browser

Astrocytoma, Brain Neoplasms, Disease, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Ganglioglioma

NCT07448480 2026-03-04

GLIOTARG

Active not recruiting

1,000 enrolled

CNS

Astrocytoma, Glioblastoma, Glioma

NCT04197934 2026-02-12

WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases

Phase 1 Active not recruiting

56 enrolled

CNSThoracic

Astrocytoma, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Lung Neoplasms

NCT00887146 2026-01-22

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Phase 3 Active not recruiting

305 enrolled

CNS

Astrocytoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT05236036 2026-01-14

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Phase 1 Active not recruiting

60 enrolled

CNS

Astrocytoma, Glioblastoma

NCT07031765 2025-12-18

Peds CHAMP1ON

Phase 1 Active not recruiting

12 enrolled

CNS

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma

NCT02192359 2025-11-14

Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Phase 1 Active not recruiting

18 enrolled 16 charts

CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT02062827 2025-10-02

M032-HSV-1

Phase 1 Active not recruiting

29 enrolled 16 charts

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Virus Diseases, Gliosarcoma

NCT06614855 2025-08-06

A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma

Phase 1 Active not recruiting

12 enrolled

CNSSarcoma

Astrocytoma, Glioblastoma, Gliosarcoma

NCT03180502 2025-07-11

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

Phase 2 Active not recruiting

120 enrolled

CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT03739372 2025-07-11

PNOC008

Phase NA Active not recruiting

44 enrolled

CNS

Astrocytoma, Glioblastoma, Glioma, Neoplasms

NCT03893487 2025-07-11

PNOC016

Phase EARLY_PHASE1 Active not recruiting

30 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Medulloblastoma

NCT03220646 2025-07-09

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Phase 2 Active not recruiting

64 enrolled

CNS

Astrocytoma, Brain Neoplasms, Ependymoma, Meningioma, Oligodendroglioma

Clinical Trials

rQNestin

GLIOTARG

WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Peds CHAMP1ON

Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

M032-HSV-1

A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

PNOC008

PNOC016

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors